Biologics Regulatory Spine Top Stories Bone Solutions Receives 510(k) Clearance for Expanded Indications of Use for Mg OSTEOCRETE in Intervertebral Body Fusion Procedures byJosh SandbergFebruary 13, 2024
Biologics Bone Solutions Inc. Successfully Surpasses 1,000 Implanted Cases with OsteoCrete® Magnesium-Based Bone Void Filler byJosh SandbergFebruary 25, 2020
Biologics Bone Solutions Inc. partners with Onkos Surgical for private label licensing agreement utilizing the OsteoCrete® platform technology byJosh SandbergAugust 28, 2019
Biologics WishBone Medical Adds Resorbable Implants to Product Offerings byJosh SandbergAugust 15, 2019
Biologics Bone Solutions Inc. Successfully surpasses 500 implanted cases with OsteoCrete® Magnesium-Based Bone Void Filler byJosh SandbergFebruary 26, 2019
Biologics Bone Solutions Inc. has successfully completed 250 cases with OsteoCrete® Magnesium-Based Bone Void Filler byJosh SandbergOctober 2, 2018
Spine In a First for the Orthopedic Industry, Bone Solutions of Dallas (BSI) Has Received Formal Patent Approval for Its Groundbreaking Magnesium Based Resorbable Bio-Material byJosh SandbergSeptember 14, 2015
